Page 8 - Pharma Companies

Price talks on Russia's Sputnik V Covid-19 vaccine yet to kick off

Rs 150/dose not ceiling price; cost to be fixed individually

Activists, drug groups split over suspending Covid-19 shot patents

Some 100 nations have expressed support, as has Doctors Without Borders (MSF) and World Health Organization head Tedros Adhanom Ghebreyesus.

Parikh family, former promoters of Zandu, exits pharma business

Sells stake in drug firm ZCL to PE firm Advent for Rs 1,600 cr

Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand

Cipla stock went up by almost 3 per cent on Tuesday

Cipla receives USFDA nod for nasal spray for treating migraine attacks

Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Sumatriptan Nasal Spray, indicated for the treatment of migraine attacks

Russian, Chinese hacking groups target pharma companies for Covid-19 data

Singapore-based cyber intelligent firm Cyfirma says 15 active hacking campaigns are underway; US, UK and Japan among a slew of other nations also on cybercriminals' target list

To end reliance on China, Indian pharma firms go local for raw materials

Though India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019

Can re-engineer Covaxin to beat South African variant: Bharat Biotech

Other vaccine makers, such as Hyderabad-based Biological E, too, have started working on different strains.

Pfizer-BioNTech vaccine stops Covid-19 spread by 90%, says study

This provides the first indication that the immunisation will curb transmission

As Covid-19 cases fall, so do sales of favipiravir and remdesivir drugs

While remdesivir is an injectable drug which is administered in hospital settings, antiviral drug favipiravir is given orally

Novavax, Serum Institute plans to supply 1.1 billion doses to COVAX

Novavax has signed a memorandum of understanding (MoU) in this regard with Gavi, the Vaccine Alliance.

States shying away from administering Bharat Bio's Covid-19 vaccine Covaxin

A month on, 21 states and UTs have not administered a single shot of the vaccine

Pharma's 3Q profitability improvement starts to taper off: Ind-Ra

The ratings agency does not expect Indian pharmaceutical companies to sustain the healthy operating margins reported during 3Q FY21 and 9M FY21

AstraZeneca Pharma India Q3 net profit declines 21% at Rs 21 crore

Drug firmAstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December

Corporate air travel takes wing on economic revival, low Covid-19 cases

Online travel portals and airlines say the demand from companies is being led by essential services sectors like pharmaceutical, oil and gas, and power

Sales of Ivermectin, drug to treat parasitic infections, jump fourfold

Mumbai-based pulmonologist Dr Agam Vora said in the first few months of the pandemic, the line of treatment was not established

Active pharmaceutical ingredients sales momentum begins to normalise

With API supply, especially from China, facing some constraints because of lockdowns in several countries, demand from global clients had shot up for Indian players

Zydus Cadila's Q3 net up 41% to Rs 527 cr on strong India biz growth

US formulations business dips 4% with revenues at Rs 1,603 cr, Q3 sees Zydus file 10 additional ANDAs with US FDA, taking total filings to 410

More Covid-19 vaccine candidates get approval for clinical trials in India

As for Bharat Biotech's chimpanzee flu virus (adenovirus) based intra-nasal vaccine candidate, the SEC recommended grant of permission for phase I trials

More Covid-19 vaccine candidates get approval for clinical trials in India

As for Bharat Biotech's chimpanzee flu virus (adenovirus) based intra-nasal vaccine candidate, the SEC recommended grant of permission for phase I trials